Table 6.
Cox univariate and multivariate analyses of cancer specific survival among 230 ccRCC patients.
| ccRCC patients (n = 230) | Univariate analysis | Multivariate analysis | ||||
|---|---|---|---|---|---|---|
| HR | 95% CI | p value | HR | 95% CI | p value | |
| Gender (F/M) | 1.228 | 0.684 - 2.204 | 0.493 | - | - | - |
| Age (years) | 1.012 | 0.991 - 1.034 | 0.269 | - | - | - |
| Tumor Size (cm) | 1.142 | 1.074 - 1.214 | < 0.001 | 1.072 | 0.895 - 1.455 | 0.497 |
| Capsule Invasion (yes/no) | 4.166 | 2.377 - 7.302 | < 0.001 | 1.390 | 0.914 - 4.633 | 0.146 |
| Vein Invasion (yes/no) | 5.811 | 3.326 - 10.155 | < 0.001 | 2.273 | 1.187 - 4.351 | 0.013 |
| Necrosis (yes/no) | 1.680 | 0.665 - 4.247 | 0.273 | - | - | - |
| T Stage (T3-T4 vs. T1-T2) | 5.735 | 3.086 - 10.658 | < 0.001 | 1.163 | 0.742 - 3.472 | 0.876 |
| N Stage (N1-N2 vs. N0/Nx) | 7.653 | 3.544 - 16.525 | < 0.001 | 2.203 | 0.893 - 5.434 | 0.086 |
| M Stage (M1 vs. M0/Mx) | 6.206 | 3.153 - 12.216 | < 0.001 | 2.129 | 0.645 - 7.026 | 0.215 |
| Clinical Stage | 2.464 | 1.859 - 3.265 | < 0.001 | 1.940 | 1.385 - 2.718 | < 0.001 |
| Furhman Grade | 1.601 | 1.183 - 2.169 | 0.002 | 1.661 | 1.179 - 2.339 | 0.004 |
| 5hmC (high/low) | 0.405 | 0.207 - 0.791 | 0.008 | 0.381 | 0.188 - 0.774 | 0.008 |